Abstract
Low bleeding rates with increase or maintenance of physical activity in patients treated with recombinant factor VIII Fc fusion protein (rFVIIIFc) in the A-LONG and Kids A-LONG Studies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have